Elevated levels of C3 and/or C3 cleavage products in the bloodstream were described in numerous pathologies, including autoimmune, neurological, renal, and cardiovascular diseases, cancer, transplant rejection, and obesity [27]. This evidence concerns the gene C3 and cancer.